NLM Digital Collections

Search

Search Constraints

Start Over You searched for: Subjects United States Remove constraint Subjects: United States Dates by Range 2000 and later Remove constraint Dates by Range: 2000 and later

Search Results

5152. Data brief: sexual and reproductive health services among people with employer sponsored insurance

5153. Gene therapies for sickle cell disease: final evidence report

5154. Resmetirom and obeticholic acid for non-alcoholic steatohepatitis (NASH): final evidence report

5155. Lecanemab for early Alzheimer’s disease: final evidence report

5156. JAK inhibitors and monoclonal antibodies for the treatment of atopic dermatitis: effectiveness and value : final evidence report

5157. Oral and monoclonal antibody treatments for relapsing forms of multiple sclerosis: effectiveness and value : final evidence report

5158. Tezepelumab for severe asthma: final report

5159. Fezolinetant for moderate to severe vasomotor symptoms associated with menopause: effectiveness and value : final evidence report

5160. Gene therapy for hemophilia B and an update on gene therapy for hemophilia A: effectiveness and value : final evidence report